Buy & Sell Howmet Aerospace Inc (HWM) – Howmet Aerospace Inc Price Today
Aura AI Summary
Key Stats
- $108.21BMarket Cap
- IndustrialsSector
- -9.88%3M Drawdown
- $110.46BEnterprise Value
- 0.18%Dividend Yield
- 6% Buy | 94% SellTrading Activity
- 14 daysTypical Hold Time
Howmet Aerospace Inc (HWM) is currently valued at a market capitalization of $108.21B, with an enterprise value of $110.46B. Over the past 52 weeks, Howmet Aerospace Inc has traded between a low of $170.23 and a high of $277.42, highlighting its annual price range. Over the past three months, Howmet Aerospace Inc has recorded a drawdown of -9.88%, reflecting recent price volatility. Howmet Aerospace Inc offers a dividend yield of 0.18%, with the most recent dividend of $0.12 paid on 08 May 26. On average, investors hold Howmet Aerospace Inc for approximately 14 days, indicating typical investor behavior on the platform.
About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Most Recent News
Global GLP-1 receptor agonist market to reach $95.3B by 2035, growing at 12.1% CAGR driven by diabetes and obesity demand.
The global GLP-1 receptor agonist market, used primarily for type 2 diabetes and obesity management, is projected to grow from $28.7 billion in 2025 to $95.3 billion by 2035, at a compound annual growth rate of 12.1%. Growth is fueled by rising diabe...

Lawsuit alleges Corcept Therapeutics hid FDA concerns about key drug approval risks
Kuehn Law is investigating Corcept Therapeutics for allegedly failing to disclose FDA concerns about the clinical development of relacorilant, a drug candidate for Cushing's syndrome. The lawsuit claims Corcept misled shareholders by promoting expect...

Investigation launched into Simulations Plus for possible false statements affecting investors.
The Schall Law Firm is investigating Simulations Plus, Inc. for potentially issuing false or misleading statements and failing to disclose important information to investors. This probe could impact shareholders who may have suffered losses due to th...
